Recro Pharma

$2.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+2.59%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell Recro Pharma and other stocks, options, and ETFs commission-free!

About REPH

Recro Pharma, Inc. Common Stock, also called Recro Pharma, is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). It offers solutions for the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose drug products. The company was founded by Geraldine A. Henwood and Thomas F. Henwood on November 15, 2007 and is headquartered in Malvern, PA. The listed name for REPH is Recro Pharma, Inc. Common Stock.

CEO
Gerri A. Henwood
Employees
215
Headquarters
Malvern, Pennsylvania
Founded
2007
Market Cap
56.27M
Price-Earnings Ratio
Dividend Yield
Average Volume
414.56K
High Today
$2.41
Low Today
$2.17
Open Price
$2.34
Volume
542.32K
52 Week High
$19.21
52 Week Low
$1.49

Collections

REPH Earnings

-$1.06
-$0.71
-$0.35
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 1, Pre-Market

You May Also Like